Inflammatory breast cancer is a fast-growing form of breast cancer where cancer cells block lymph vessels in the skin, causing the breast to become red, swollen, and warm
Inflammatory breast cancer (IBC) accounts for 1 to 5 percent of all breast cancers diagnosed in the United States. It is not caused by an infection or injury, despite the inflammatory appearance. Instead, cancer cells have spread to the lymph vessels in the skin of the breast, blocking the flow of lymph fluid. This blockage causes the characteristic redness, swelling, and warmth that give the disease its name.
The condition develops quickly—often over weeks or a few months—which is why it is sometimes called a medical emergency. Because the cancer cells have already reached the lymph system by the time symptoms appear, IBC is always considered stage III or stage IV at diagnosis. This means it has either spread to nearby lymph nodes or to distant parts of the body.
Key Takeaways
- Inflammatory breast cancer causes visible redness, swelling, and dimpling of the breast skin that develops rapidly, often within weeks.
- The disease is always advanced at diagnosis because cancer cells have already spread to lymph vessels or beyond the breast.
- Symptoms can resemble a breast infection, but antibiotics do not improve IBC, which is a key difference doctors use to distinguish it.
- Treatment typically combines chemotherapy before surgery, followed by radiation and sometimes additional therapy, rather than surgery first.
- Survival rates depend on whether the cancer has spread to distant organs, but early recognition and prompt treatment improve outcomes.
How inflammatory breast cancer looks and feels
The skin of the affected breast becomes red or dark pink, often in a patchy pattern. The redness may cover a large area or the entire breast. The skin typically feels warm to the touch, and the breast becomes noticeably swollen and tender. Many people describe a heaviness or fullness in the breast.
A distinctive feature is peau d'orange (French for "orange peel"), a dimpled or textured appearance of the skin caused by swelling of the tissue beneath. The nipple may become inverted or flattened. These changes happen quickly—sometimes within two to three weeks—which sets IBC apart from other breast cancers that often develop slowly over months or years.
Because these symptoms resemble a breast infection (mastitis), many people are initially treated with antibiotics. If the redness and swelling do not improve within a week of starting antibiotics, or if no infection is found on imaging, a doctor should consider IBC and order a biopsy.
Why inflammatory breast cancer spreads so quickly
Cancer cells in IBC produce substances that cause inflammation and block lymph vessels in the skin. This blockage prevents the immune system from containing the cancer cells locally. The cancer cells can then move into the bloodstream and travel to other parts of the body more easily than in other forms of breast cancer.
The cancer cells themselves are often aggressive—meaning they divide rapidly and are less responsive to hormones like estrogen and progesterone. About 70 percent of IBC cases are triple-negative, meaning the cancer cells lack receptors for estrogen, progesterone, and a protein called HER2. This makes hormone-based treatments ineffective and limits treatment options compared to other breast cancers.
How doctors diagnose inflammatory breast cancer
Diagnosis begins with a physical exam and imaging. A doctor will order a mammogram and ultrasound to look at the breast tissue. An MRI may also be done to see how far the cancer has spread within the breast and to nearby lymph nodes.
A biopsy is necessary to confirm the diagnosis. During a biopsy, a small sample of breast tissue is removed with a needle or through a small surgical cut and examined under a microscope for cancer cells. The pathologist also tests the cells to determine whether they have estrogen, progesterone, or HER2 receptors, which guides treatment decisions.
Because IBC is always advanced, additional imaging of the lungs, liver, and bones is done to check whether cancer has spread to distant organs. This staging information determines the prognosis and treatment plan.
Treatment approaches for inflammatory breast cancer
Treatment for IBC differs from treatment for earlier-stage breast cancers. Most people receive neoadjuvant chemotherapy first—chemotherapy given before surgery to shrink the tumor. This is followed by surgery to remove the breast and nearby lymph nodes (a procedure called a mastectomy). After surgery, radiation therapy is given to the chest wall and lymph node areas.
Some people also receive additional therapy after radiation, such as hormone therapy (if the cancer has hormone receptors) or targeted therapy directed at specific mutations in the cancer cells. The exact combination depends on the characteristics of the cancer and how well it responds to initial chemotherapy.
Clinical trials are testing newer approaches, including immunotherapy drugs that help the immune system recognize and attack cancer cells. Because IBC is rare and aggressive, treatment plans are often individualized, and a doctor specializing in breast cancer (a medical oncologist) should be involved in decisions.
Survival and prognosis for inflammatory breast cancer
The five-year survival rate for IBC is lower than for other breast cancers, but outcomes have improved over the past two decades as treatment has become more aggressive and targeted. The National Cancer Institute reports that five-year survival varies based on whether the cancer has spread to distant organs at diagnosis.
Factors that influence prognosis include the age of the person at diagnosis, the size of the tumor, whether lymph nodes are involved, whether the cancer has spread to distant organs, and the genetic characteristics of the cancer cells. People diagnosed at a younger age and those whose cancer shrinks significantly with chemotherapy tend to have better outcomes.
Regular follow-up appointments with an oncologist are important after treatment ends. These visits monitor for signs of recurrence and manage any long-term effects of chemotherapy or radiation.
Frequently Asked Questions
Is inflammatory breast cancer caused by an infection?
No. IBC is caused by cancer cells blocking lymph vessels in the breast skin, not by bacteria or a virus. The redness and swelling resemble an infection, which is why it is sometimes mistaken for mastitis. However, antibiotics do not treat IBC, and if symptoms do not improve with antibiotics, further testing is needed.
Can inflammatory breast cancer be prevented?
There is no known way to prevent IBC. Risk factors include being female, being over age 40, and possibly obesity or recent pregnancy, but many people with these factors never develop the disease. Because IBC cannot be prevented, early recognition of symptoms and prompt medical evaluation are the most important steps.
What is the difference between inflammatory breast cancer and regular breast cancer?
Regular breast cancers often start as a lump and may not cause visible skin changes. IBC causes rapid visible changes—redness, swelling, and dimpling—because cancer cells block lymph vessels in the skin. IBC is always stage III or IV at diagnosis, while other breast cancers may be caught at earlier stages. Treatment also differs: IBC typically requires chemotherapy before surgery, whereas earlier-stage cancers often have surgery first.
Can men get inflammatory breast cancer?
Yes, though it is rare. About 1 percent of breast cancers occur in men, and IBC makes up a small fraction of those. Men with IBC have the same symptoms—redness, swelling, and skin changes—and receive the same types of treatment as women.
How quickly does inflammatory breast cancer spread?
IBC develops and spreads faster than most other breast cancers. Symptoms often appear within weeks to a few months. By the time diagnosis is made, the cancer has already reached lymph vessels in the breast skin and often nearby lymph nodes. Some people have distant spread to the lungs, liver, or bones at diagnosis, though not all do.